List of Mati Therapeutics patents

Patents where

Current Assignee

Name

Mati Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8628792 Drug cores for sustained release of therapeutic agents	Patent 8628792 was granted and assigned to Mati Therapeutics on January, 2014 by the United States Patent and Trademark Office.		Mati Therapeutics	United States Patent and Trademark Office	8628792	January 14, 2014
‌ US Patent 11406532 Static pin insertion tool for lacrimal implant	Patent 11406532 was granted and assigned to Mati Therapeutics on August, 2022 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	11406532	August 9, 2022
‌ US Patent 11324693 Ophthalmic drug sustained release formulation and uses thereof	Patent 11324693 was granted and assigned to Mati Therapeutics on May, 2022 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	11324693	May 10, 2022
‌ US Patent 10300014 Nasolacrimal drainage system implants for drug therapy	Patent 10300014 was granted and assigned to Mati Therapeutics on May, 2019 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	10300014	May 28, 2019
‌ US Patent 11406592 Drug delivery methods, structures, and compositions for nasolacrimal system		Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	11406592	August 9, 2022
‌ US Patent 9610194 Drug delivery methods, structures, and compositions for nasolacrimal system	Patent 9610194 was granted and assigned to Mati Therapeutics on April, 2017 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	9610194	April 4, 2017
‌ US Patent 9849082 Nasolacrimal drainage system implants for drug therapy	Patent 9849082 was granted and assigned to Mati Therapeutics on December, 2017 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	9849082	December 26, 2017
‌ US Patent 9011361 Lacrimal implant detection	Patent 9011361 was granted and assigned to Mati Therapeutics on April, 2015 by the United States Patent and Trademark Office.		Mati Therapeutics	United States Patent and Trademark Office	9011361	April 21, 2015
‌ US Patent 9949942 Sustained release delivery of active agents to treat glaucoma and ocular hypertension	Patent 9949942 was granted and assigned to Mati Therapeutics on April, 2018 by the United States Patent and Trademark Office.		Mati Therapeutics	United States Patent and Trademark Office	9949942	April 24, 2018
‌ US Patent 8702643 Lacrimal implants and related methods	Patent 8702643 was granted and assigned to Mati Therapeutics on April, 2014 by the United States Patent and Trademark Office.		Mati Therapeutics	United States Patent and Trademark Office	8702643	April 22, 2014
‌ US Patent 10434009 Lacrimal implants and related methods	Patent 10434009 was granted and assigned to Mati Therapeutics on October, 2019 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	10434009	October 8, 2019
‌ US Patent 9763824 Lacrimal implants and related methods	Patent 9763824 was granted and assigned to Mati Therapeutics on September, 2017 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	9763824	September 19, 2017
‌ US Patent 11633300 Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device	Patent 11633300 was granted and assigned to Mati Therapeutics on April, 2023 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	11633300	April 25, 2023
‌ US Patent 9463114 Punctal plug with active agent	Patent 9463114 was granted and assigned to Mati Therapeutics on October, 2016 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	9463114	October 11, 2016
‌ US Patent 9445944 Lacrimal implants and related methods	Patent 9445944 was granted and assigned to Mati Therapeutics on September, 2016 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	9445944	September 20, 2016
‌ US Patent 9764066 Composite lacrimal insert and related methods	Patent 9764066 was granted and assigned to Mati Therapeutics on September, 2017 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	9764066	September 19, 2017
‌ US Patent 9132088 Composite lacrimal insert and related methods	Patent 9132088 was granted and assigned to Mati Therapeutics on September, 2015 by the United States Patent and Trademark Office.		Mati Therapeutics	United States Patent and Trademark Office	9132088	September 15, 2015
‌ US Patent 10874606 Nasolacrimal drainage system implants for drug therapy	Patent 10874606 was granted and assigned to Mati Therapeutics on December, 2020 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	10874606	December 29, 2020
‌ US Patent 10383817 Nasolacrimal drainage system implants for drug therapy	Patent 10383817 was granted and assigned to Mati Therapeutics on August, 2019 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	10383817	August 20, 2019
‌ US Patent 8691265 Drug delivery methods, structures, and compositions for nasolacrimal system	Patent 8691265 was granted and assigned to Mati Therapeutics on April, 2014 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	8691265	April 8, 2014
‌ US Patent 9610271 Sustained release delivery of active agents to treat glaucoma and ocular hypertension	Patent 9610271 was granted and assigned to Mati Therapeutics on April, 2017 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	9610271	April 4, 2017
‌ US Patent 8795711 Drug delivery methods, structures, and compositions for nasolacrimal system	Patent 8795711 was granted and assigned to Mati Therapeutics on August, 2014 by the United States Patent and Trademark Office.		Mati Therapeutics	United States Patent and Trademark Office	8795711	August 5, 2014
‌ US Patent 8747884 Nasolacrimal drainage system implants for drug therapy	Patent 8747884 was granted and assigned to Mati Therapeutics on June, 2014 by the United States Patent and Trademark Office.		Mati Therapeutics	United States Patent and Trademark Office	8747884	June 10, 2014
‌ US Patent 10603274 Ophthalmic drug sustained release formulation and uses thereof	Patent 10603274 was granted and assigned to Mati Therapeutics on March, 2020 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	10603274	March 31, 2020
‌ US Patent 9549852 Scleral and conjuctival implants for drug therapy	Patent 9549852 was granted and assigned to Mati Therapeutics on January, 2017 by the United States Patent and Trademark Office.	Mati Therapeutics	Mati Therapeutics	United States Patent and Trademark Office	9549852	January 24, 2017

Results per page:

36 results

0 selected

36 results

0 selected